Virica Biotech

#ATWEurope is just around the corner! Join us in beautiful Barcelona next week! Meet with Azra Benson to learn how Viral Sensitizers (VSE™), paired with High Throughput Virology (HTV™) and Design of Experiments (DoE), empower cell and gene therapy manufacturers to: ✔️ Improve yield and quality without disrupting existing processes ✔️ Accelerate production timelines ✔️ Reduce production costs so you save more! Whether you're advancing therapies for rare diseases or developing next-gen vaccines, let's make scaling a reality! Learn more: https://lnkd.in/gyK-FTCH #ATWEurope #innovation #biomanufacturing 

🐾 Day 1 of #AHSummit25 at the historic #MidlandTheater was action-packed! With a strong focus on nurturing the youth of today to be the success of tomorrow, #AHSummit25 launched its exploreahcareers.com website to provide a unique platform for resources on getting involved in shaping the future of #agriculture and #animalhealth.    💡 The Kansas City Animal Health Corridor is truly a vital hub, showcasing innovation, addressing obstacles, and connecting minds to drive solutions. #ViricaBiotech is proud to play a part in advancing #veterinaryvaccines. Don’t miss Azra Benson and Andrea Vervoort on day 2 of #AHSummit25, let’s explore how Virica can support your work!   #AHSummit25 #animalhealth #innovation #youreourkindofanimal

💡 It’s time we look beyond traditional veterinary vaccines. Viral vectors are already delivering real wins across species and hinting at what’s next. Standouts across species: ✔️ Poultry: fowlpox-based avian influenza vaccines with durable flock protection ✔️ Dogs: adenoviral vectors for canine distemper ✔️ Cattle: herpesvirus vectors for IBR ✔️ Aquaculture: DNA/vector constructs tailored to fish pathogens From bench to barn, can it scale? 🔸 Scale-up remains complex; platforms aren’t equally “factory-ready.” 🔸 Lentiviral vectors face well-known large-scale hurdles 🔸 Delivery tech can waste dose (e.g., microneedles) and add variability 🔸 Pre-existing anti-vector immunity complicates boosting Beyond today’s toolbox, what's next? 🔹 Smarter vectors that broaden tropism and dodge immunity 🔹 Stability-focused delivery and next-gen adjuvants 🔹 Species-tuned formulations guided by systems biology 🔹 One-Health strategies targeting zoonoses and cross-species threats Here's the bottom line Viral vector vaccines are maturing in animal health, but scaling, vector neutralization, and reproducible delivery are the bottlenecks. The next leap comes from pairing smarter vectors with manufacturing built for scale. At Virica, we provide a simple solution to achieve manufacturing scale: Our VSE™ boost viral vector yield and quality. Make scaling your innovative animal health therapies a reality without changing your process. If you’re at the Animal Health Summit in Kansas next week, let’s connect! #AnimalHealth #Vaccines #ViralVectors #Biomanufacturing #VetMed

📣 We’re at the Kansas Animal Health Summit next week! 🐾 Azra Benson and Andrea Vervoort are excited to connect with industry peers, meet potential partners, and hear from innovators shaping the future of animal health. We’re especially eager to connect with partners focused on advancing vaccines and therapeutics for livestock and companion animals. If you’re attending, let’s collaborate on treatments and preventative therapies that transform animal health! 🌐 Visit our website to learn more: https://lnkd.in/gyK-FTCH #innovation #animalhealth #AHSummit25

We believe in empowering our team members to support initiatives that promote social well-being and community resilience. Patrick Miron has taken this to heart through his work managing Taekwondo camps in Nunavik. "I would like to extend my sincere gratitude to Virica for their ongoing support, particularly in their flexible approach to my work schedule. Virica’s support has been instrumental in allowing me to manage the Taekwondo camps in Nunavik, in alignment with their commitment to fostering safe and healthy communities through initiatives like the Makivvik Ungaluk Safer Communities Program. I appreciate Virica’s dedication to promoting culturally appropriate measures that support social well-being and crime prevention in Nunavik." We’re proud to support initiatives that strengthen communities and empower our people to make a difference.

🐾 Virica is making its Animal Health Summit debut! On August 25th & 26th, we will be in Kansas City for the Animal Health Corridor Summit, connecting with leaders and innovators shaping the future of animal health. 💡 Virica’s solutions have helped manufacturers increase viral vector yields, reduce production costs, and maintain high-quality standards without altering existing processes. These same advantages are just as crucial in the animal health market. With global demand for animal vaccines rising, there’s a pressing need for manufacturing approaches that can deliver speed, scalability, and cost-efficiency. If you’re attending, meet with Azra Benson and Andrea Vervoort! We would love to connect and explore how Virica’s innovations can support your work. Connect with us to learn more: https://lnkd.in/e3zvChi #AnimalHealthSummit #biomanufacturing #innovation

📣 The recent Next Gen Gene Therapy Summit puts smarter viral-vector manufacturing center stage! Here are 3 takeaways from the Gene Therapy Vector Summit that stood out! 👇 🧬 Whether you’re on your first therapy or scaling your tenth, Virica’s VSE™ and HTV™ workflows accelerate production and cut costs. 🔗 Learn more: https://lnkd.in/gu2m3RcX 💡 Subscribe to our insights: https://lnkd.in/d-rf3XVX #biomanufacturing #innovation #celltherapy #genetherapy

Congratulations to Culture Biosciences and Cytiva on the new strategic partnership! 🚀 Exciting to see this collaboration set new standards for scalable, cloud-enabled bioprocessing, making cutting-edge technology more accessible to biopharma innovators. At Virica, we're proud to support both Culture and Cytiva in advancing bioprocessing! Our Viral Sensitizers (VSE™) boost productivity in Culture’s Stratyx™ 250 and Cytiva’s iCELLis™ Nano fixed-bed bioreactor without process disruption. Read Full Whitepaper: https://lnkd.in/dii9ge_k #biomanufacturing #innovation #CGT

At Virica, we understand regulatory readiness is key to clinical success. 💡 That’s why our GMP-grade Viral Sensitizers (VSE™) are designed to integrate seamlessly into your upstream process, boosting yields by 2–5x without disrupting your workflow. What this means for your process: 🔹 Ancillary material classification: add VSEs with confidence. 🔹 Regulatory‑ready: residual assays, Drug Master Files (DMF), Regulatory Support Files (RSF) and supporting data for smooth submissions. 🔹 With you every step from screening to scale‑up. Smarter process. Faster results. Confident compliance. ✔️ Learn more: https://lnkd.in/gyK-FTCH #biomanufacturing #innovation #GMP

🤔 Missed our Industry Insights last week? 💡 From the FDA dismantling barriers to CAR‑T access, to single‑shot AAV restoring hearing, and platform vectors fast‑tracking approvals, this month’s industry snapshot points to faster innovation, renewed investor confidence, and expanded patient access despite recent setbacks. 👉 Check out our Industry Insights Series: https://lnkd.in/d-3PBiVx #innovation #biomanufacturing #cgtreads